Skip to content
Recall Observatory FDA recall evidence

Drug product

Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent Pharma Inc., Buena, NJ 08310, NDC 52565-009-50

D-0281-2022

October 12, 2021

Class II

Product summary

Firm
Teligent Pharma, Inc.
Event
Event 88850
Status
Terminated
Classification
Class II
Quantity
14,664 glass bottles
Official record key
drug-enforcement:D-0281-2022

Official wording

Reason: CGMP Deviations: Lots recalled because they were manufactured at the same facility using the same components as the products that had cracked seals in caps that were found to be superpotent.

Code information: Lot #: 13058, Exp. date 02/2022 and 13768, Exp. date 05/2022

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations
  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    superpotent